|
Market Closed -
Nasdaq
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 2.260 USD | +3.20% |
|
-4.24% | +38.65% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-20 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
Company Valuation: Ovid Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 218.6 | 131.1 | 227.6 | 66.3 | 212.2 | 427.7 | - | - |
| Change | - | -40.04% | 73.64% | -70.87% | 220.05% | 101.56% | - | - |
| Enterprise Value (EV) 1 | 218.6 | 131.1 | 227.6 | 66.3 | 212.2 | 300.7 | 96.5 | -113.4 |
| Change | - | -40.04% | 73.64% | -70.87% | 220.05% | 41.71% | -67.91% | -217.51% |
| P/E | 1.82x | -2.42x | -4.35x | -2.52x | -7.09x | -5.91x | -5.58x | -5.03x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 1.12x | 0.1x | 0.2x | -0.1x | -0.95x | -0.5x |
| Capitalization / Revenue | 1.05x | 87.2x | 581x | 117x | 29.3x | 535x | 2,298x | 2,044x |
| EV / Revenue | 1.05x | 87.2x | 581x | 117x | 29.3x | 376x | 519x | -542x |
| EV / EBITDA | 1.76x | -2.38x | -3.95x | -1.1x | - | -4.25x | -1.11x | 0.87x |
| EV / EBIT | 1.47x | -2.36x | -3.84x | -1.07x | -5x | -4.23x | -1.12x | 1.05x |
| EV / FCF | - | - | - | - | -5.54x | -4.26x | -1.17x | 1.06x |
| FCF Yield | - | - | - | - | -18.1% | -23.5% | -85.2% | 94.4% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.76 | -0.77 | -0.74 | -0.37 | -0.23 | -0.3708 | -0.3925 | -0.435 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 208.4 | 1.503 | 0.3917 | 0.566 | 7.252 | 0.7992 | 0.1861 | 0.2092 |
| EBITDA 1 | 124.4 | -55.04 | -57.68 | -60.18 | - | -70.8 | -86.7 | -130.4 |
| EBIT 1 | 149.2 | -55.55 | -59.28 | -61.88 | -42.44 | -71.08 | -86.17 | -108 |
| Net income 1 | 122.8 | -54.17 | -52.34 | -26.43 | -17.41 | -68.57 | -84.06 | -105.5 |
| Net Debt 1 | - | - | - | - | - | -127 | -331.2 | -541.1 |
| Reference price 2 | 3.210 | 1.860 | 3.220 | 0.934 | 1.630 | 2.190 | 2.190 | 2.190 |
| Nbr of stocks (in thousands) | 68,092 | 70,467 | 70,681 | 71,010 | 130,184 | 195,298 | - | - |
| Announcement Date | 3/15/22 | 3/13/23 | 3/8/24 | 3/11/25 | 3/18/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.91x | 376.23x | -4.25x | - | 428M | |
| 20.03x | 7.14x | 14.3x | 1.48% | 68.92B | |
| 27.94x | 7.65x | 24.01x | 0.05% | 51.9B | |
| 34.21x | 6.11x | 18.26x | 0.95% | 48.73B | |
| 33.07x | 3.27x | 14.12x | -.--% | 43.13B | |
| -20.06x | 203.22x | -21.36x | -.--% | 41.48B | |
| 46.56x | 5.29x | 29.06x | -.--% | 39.96B | |
| 26.85x | 7.63x | 19.75x | 0.4% | 30.6B | |
| 30.04x | 6.38x | 16.56x | -.--% | 26.01B | |
| -13.53x | 5x | -6.04x | -.--% | 22.27B | |
| Average | 17.92x | 62.79x | 10.44x | 0.32% | 37.34B | |
| Weighted average by Cap. | 22.10x | 28.49x | 13.13x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OVID Stock
- Valuation Ovid Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
